Joseph Loscalzo Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 8 hours ago
Joseph Loscalzo has an estimated net worth of at least $12.2 million*, as of June 24, 2026. They own 47,298 shares of IONS stock. They have sold 123,829 shares of IONS stock since 2021, for an estimated $8.6 million.
Joseph Loscalzo $IONS SEC Form 4 Insider Trading
Joseph Loscalzo has filed a total of 7 insider trades in $IONS since 2021. Their most recent trade was a sale of 59,508 shares, made on May 04, 2026. Their largest trade was a sale of 59,508 shares, made on May 04, 2026. We estimate that they now own 47,298 shares of $IONS, worth an estimated $3.6 million.
Insider Trading at $IONS
There have been a total of 308 insider trades reported at $IONS since 2021, with 20,000 shares purchased and 3.3 million shares sold. The most active insider traders in $IONS stock have been Brett P Monia, Eric Swayze, and Patrick R. O'Neil. The most recent trade was a sale of 5,635 shares reported by Joseph Baroldi (EVP, Chief Business Officer), made on Jun 26, 2026.
History of Insider Stock Trades by Joseph Loscalzo
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
IONS
|
Sale | 59,508 | May 04, 2026 | May 6, 2026, 5:27 p.m. |
|
IONS
|
Sale | 17,781 | May 04, 2026 | May 6, 2026, 5:27 p.m. |
|
IONS
|
Sale | 832 | Mar 03, 2026 | March 5, 2026, 7:14 p.m. |
|
IONS
|
Sale | 200 | Mar 04, 2026 | March 5, 2026, 7:14 p.m. |
|
IONS
|
Sale | 16,000 | Oct 31, 2025 | Nov. 3, 2025, 9:14 p.m. |
|
IONS
|
Sale | 16,000 | Sep 03, 2025 | Sept. 4, 2025, 8:28 p.m. |
|
IONS
|
Sale | 13,508 | Nov 12, 2024 | Nov. 14, 2024, 6:30 p.m. |
$IONS Executives and Stock Owners with Insider Trades
-
Brett P Monia, Chief Executive Officer
-
Eric Swayze, EVP Research
-
Patrick R. O'Neil, EVP CLO & General Counsel
-
Joseph Baroldi, EVP, Chief Business Officer
-
Richard S Geary, EVP, Chief Development Officer
-
C Frank Bennett, EVP, Chief Scientific Officer
-
Shannon L. Devers, EVP, Chief Human Resources Ofc
-
Eugene Schneider, EVP, Chf Clinical Develop Ofcr
-
Elizabeth L Hougen, EVP, Finance & CFO
-
Brian Birchler, EVP, Corp and Development Ops
-
Onaiza Cadoret-Manier, EVP, Chf GL Pdt Str & Oper Ofc
-
Holly B. Kordasiewicz, EVP, Chief Development Officer
-
Kyle Jenne, EVP, Chf GL Pdt Str Ofcr
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.